AU Patent

AU2013202756B2 — Pharmaceutical composition containing a tetrahydrofolic acid

Assigned to Bayer Intellectual Property GmbH · Expires 2015-06-04 · 11y expired

What this patent protects

PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROFOLIC ACID The present invention relates to solid pharmaceutical compositions, in particular to oral contraceptives, comprising a progestogen, such as drospirenone, an estrogen, such as ethinylestradiol; a tetrahydrofolic acid or …

USPTO Abstract

PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROFOLIC ACID The present invention relates to solid pharmaceutical compositions, in particular to oral contraceptives, comprising a progestogen, such as drospirenone, an estrogen, such as ethinylestradiol; a tetrahydrofolic acid or a pharmaceutically acceptable salt thereof, such as calcium 5-methyl-(6S)-tetrahydrofolate; and at least one pharmaceutically acceptable excipient or carrier. The compositions of the invention provide good stability of the tetrahydrofolic acid upon storage while still ensuring a fast and reliable release of the estrogen and the progestogen present in the composition.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013202756B2
Jurisdiction
AU
Classification
—
Expires
2015-06-04
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Intellectual Property GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.